Company Profile
President and CEO
Takuya Iwabuchi
< Social Contribution >
Visiting Professor, National Institute of Technology and Ichinoseki College of Technology
Adjunct Lecturer, Akita University Graduate School of Medicine and Engineering Science
Expert Researcher, Institute for Science, Technology and Academic Policy, the Ministry of Education, Culture, Sports, Science and Technology
< Award >
2017
2018
2020
2021
2022
2023
Japan Venture Award 2017 SME President's Award
Tohoku Entrepreneur Award
SMBC Startup Competition Grand Prize
Nihon Keizai Shimbun Star ☆ Atpitch Japan Resona Bank Award
Award of the Commissioner of the Japan Patent Office for Local Inventions and Achievement Award
the Ministry of Health, Labour and Welfare Appreciation Certificate Award for Antigen Test Kit Supply Business
Winner of the 9th Monozukuri Japan Grand Prize and Excellence Award
Company name
Cellspect Co., Ltd.
April 18, 2014
Establishment
Board members
President and CEO Takuya Iwabuchi
Executive director Kazuhiro Koide
Executive officer and CTO Wataru Hojo
Outside director Keiji Katano
（President of Icomes Lab Co., Ltd.）
Outside director Kinichiro Kominami
（President of Tech & FinStrategy, Inc.）
Auditor Mieko Mio（Lawyer）
Auditor Hiroshi Akasaka
Capital
1.38 billion JPY (capital reserve included)
Location
Head office 2-4-23, Kitaiioka, Morioka-shi,
Iwate, Japan
Employees
39 (as of March 31, 2024)
Major Shareholder
Mizuho Capital Co., Ltd.
Iwagin Business Creation Capital Co., Ltd.
Mitsubishi UFJ Capital Co., Ltd.
Yakuodo Holdings Co., Ltd. etc.
Main bank
Tohoku Bank, Ltd. / The Bank of Iwate, Ltd. / Japan Finance Corporation / Kita-Nippon Bank, Ltd.
Acquisition license/approval
License No. for type 2 medical device manufacturing & marketing business: 03B2X10003
Registration No. for medical device manufacturer: 03BZ200026
License No. for selling and leasing operations for specially-controlled medical devices: Morioka city No. 607
License No. for marketing and manufacturing of in-vitro diagnostics: 03E1X00001
Registration No. for manufacturing of in-vitro diagnostics: 03EZ200004
License No. for pharmaceuticals wholesale distribution: Iwate prefectural No. 273
Registration No. for clinical laboratory: Morioka city No. 35
Core competency
Opening up the future with biomarker sensing technology
Biomarker R&D
Infections, vaccines, oncogenes, nucleic acids, and chronic diseases
Depression/schizophrenia marker
Urinary biopyrrin
Circulating tumor cell markers
CellContact ™️
Item & system R&D
Device; sensor; probe; novel method
CTC targeting aptamer probe
CT-Capt
Gold nanoparticle nucleic acid probe
AG screen
Periodontal disease test kit
Check your mouth®
EAOC probe
TEAS
＊1
＊2
＊１ EAOCEndometriosis-Associated Ovarian Carcinoma (EAOC)
＊２ Transvaginal Endometriosis Cyst Analysis System (TEAS)
Product service release
IVD & medical equipment
Clinical testing services
Health tech items
Packaged test service
Ready to Use Reagent
IVD drugs
Policy
Business strategy
One-stop release of multiple products and services from a single biomarker
Make full use of the latest biosensing technology !
Shifting from the clinical market to the health tech market !
